Is neutrophil count a marker for risk of prostate cancer mortality?

A recent article in the journal BMC Cancer has suggested a strong association between neutrophil count and risk for overall mortality among a cohort of Canadian men treated for prostate cancer with radiation therapy ± androgen deprivation therapy (ADT). … READ MORE …

The increasing incidence of neuroendocrine forms of prostate cancer

A newly published analysis by a research team at Southern Illinois University School of Medicine has teased out some additional information about the well-recognized increase in the incidence of neuroendocrine forms of prostate cancer over the past 20 or so years. … READ MORE …

New STAMPEDE data support earlier CHAARTED trial results

So here’s the first important finding that will be presented at the upcoming annual meeting of the American Society for Clinical Oncology (ASCO) annual meeting in Chicago. Data from the UK’s STAMPEDE trial show a significant benefit from combining docetaxel-based chemotherapy with androgen deprivation therapy (ADT) in appropriately selected men. … READ MORE …

Statin therapy appears to extend progression-free survival for men on ADT

A combination of two studies by a group of researchers at the Dana-Farber Cancer Institute in Boston has provided some further evidence of the potential benefits of statin therapy for men being treated with androgen deprivation therapy (ADT) … but the evidence is preliminary and needs validation. … READ MORE …

Extending life in late-stage prostate cancer, but extending quality of life too

An article in the April issue of Lancet Oncology has provided additional data from the randomized, double-blind Phase III PREVAIL trial of enzalutamide versus placebo in men with asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (mCRPC). … READ MORE …

Long-term survival of hormone-naive patients in biochemical failure post-surgery

A new paper in the European Journal of Nuclear Medicine and Molecular Imaging provides some interesting data on the long-term survival of men with progressive prostate cancer after initial treatment by radical prostatectomy. … READ MORE …

Survival times among men with biochemically recurrent prostate cancer

It would hardly come as a shock to most experienced prostate cancer advocates and patients to learn that there is an association between survival time and the aggressiveness of a patient’s cancer at the time of diagnosis if that cancer progresses. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,295 other followers